Record Citations | HathiTrust Digital Library

Available Indexes

Back to Record

Back to Record

FDA integrity issues :
hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on Visx Inc. document disclosure, July 31, 1996.

APA Citation

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations. (1996). FDA integrity issues: hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on Visx Inc. document disclosure, July 31, 1996. Washington: U.S. G.P.O. .

MLA Citation

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations. FDA Integrity Issues: Hearing Before the Subcommittee On Oversight And Investigations of the Committee On Commerce, House of Representatives, One Hundred Fourth Congress, Second Session, On Visx Inc. Document Disclosure, July 31, 1996. Washington: U.S. G.P.O. , 1996.

Warning: These citations may not always be complete (especially for serials).